NDRI works with a network of hospital pathology departments to recover surgically removed tissue for biomedical research use. Recovered tissues have a post-surgery to preservation interval of less than four hours and can be delivered to researchers within 24 hours. Normal or diseased tissues can be sent to researchers fresh in media with antibiotics, frozen or fixed.
Examples of surgically removed tissue samples include:
Tumor samples — primary or metastatic cancer
Normal adjacent tissue (NAT)
Normal skin and adipose tissues from resections/reductions (abdominoplasty, panniculectomy, breast reductions)
Diseased cartilage from total knee replacements
Diseased tissue from bowel resections
Tonsils and spleen
We work directly with you to customize recovery protocols to ensure that you receive the highest quality samples for your studies. You will receive a final pathology report, if applicable, as soon as the information becomes available following the recovery.
Other Services and Capabilities:
Tissue and Organ Procurement - Ocular Procurement - Biospecimen Inventory - HTORR Program
If you have questions, please contact NDRI at (800) 222-NDRI (6374), ext. 391 or email us at research@ndriresource.org.
NDRI has provided thousands of tumor samples to many of the country's leading scientists for DNA and RNA research, the development of cancer cell lines, and the discovery of new drug targets and biomarkers.
Specimens are available from a large variety of cancer types within four hours’ post excision. In addition to tumor samples, we can provide:
See how other investigators have benefitted from NDRI's Cancer Program: Genetics of Breast Cancer
NDRI supports stem cell research to help scientists better understand the mechanism of stem cell growth and proliferation in order to develop therapies that may one day be used to treat a host of common diseases.
We provide birth tissue, including cord blood, umbilical cord, placenta and foreskin, all recovered fresh from surgical discard. In particular, Umbilical cord blood is a plentiful and rich source of stem cells currently being studied to treat a variety of diseases.
NDRI is a Not-For-Profit (501c3) Corporation.